T1144 |
Lidocaine hydrochloride
|
73-78-9
|
98%
|
|
Lidocaine hydrochloride is a local anesthetic and cardiac depressant used as an antiarrhythmic agent. Its actions are more intense and its effects more prolonged...
|
T6057 |
URMC-099
|
1229582-33-5
|
98%
|
|
URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM)...
|
T21295 |
BIX02189
|
1265916-41-3
|
98%
|
|
BIX02189 is a potent and selective inhibitor of MEK5 and ERK5(IC50 : 1.5 nM and 59 nM).
|
T5857 |
Trametinib (DMSO solvate)
|
1187431-43-1
|
98%
|
|
Trametinib DMSO solvate is a Highly Potent and Selective MEK Inhibitor that specifically inhibits MEK1/2(IC50 :2 nM)
|
T0468 |
Lidocaine
|
137-58-6
|
98%
|
|
Lidocaine is an amide local anesthetic with anti-inflammatory properties in vitro and in vivo. It has this functions perhaps due to an attenuation of intracellul...
|
T6692 |
TAK-733
|
1035555-63-5
|
98%
|
|
MEK Inhibitor TAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
|
T3623 |
Cobimetinib
|
934660-93-2
|
98%
|
|
Cobimetinib is a selective inhibitor of mitogen-activated protein kinase kinase (MEK) (IC50: 0.9 nM). Cobimetinib specifically binds to and inhibits the catalyti...
|
T27242 |
EF24
|
342808-40-6
|
98%
|
|
EF24 treatment increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK. EF24 shows potent anti-tumor activity i...
|
T2836 |
Isorhamnetin
|
480-19-3
|
98%
|
|
Isorhamnetin is the methylated metabolite of quercetin. Quercetin is an important dietary flavonoid with in vitro antioxidant activity. Isorhamnetin prevents end...
|
T6785 |
BI-847325
|
1207293-36-4
|
98%
|
|
BI-847325 is a selective dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.
|
T2378 |
RGB-286638 free base
|
784210-88-4
|
98%
|
|
RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin T1-CDK9/cyclin B1-CDK1/cyclin E-CDK2/cyclin D1-CDK4/cyclin E-CDK3...
|
T2708 |
SL327
|
305350-87-2
|
98%
|
|
SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 μM/0.22 μM; able to transport through the blood-brain barrier.
|
T7742 |
GW 284543 hydrochloride
|
179246-08-3
|
98%
|
|
GW 284543 hydrochloride is a selective inhibitor of MEK5 .
|
TMS2181 |
Trans-Zeatin
|
1637-39-4
|
98%
|
|
Trans-Zeatina is the member of the plant growth hormone family known as cytokinins, which regulate cell division, development, and nutrient processing.
|
T6066 |
SCH772984
|
942183-80-4
|
98%
|
|
SCH 772984 is a potent inhibitor of ERK1/ERK2 (IC50: 4/1 nM) and has only weak inhibitory for other 300 tested kinases.
|
T2508 |
Binimetinib
|
606143-89-9
|
98%
|
|
Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
|
T6218 |
Selumetinib
|
606143-52-6
|
98%
|
|
Selumetinib (AZD6244) is an effective, specific inhibitor of MEK1 and ERK1/2 phosphorylation (IC50: 14/10 nM).
|
T6971 |
Ro 5126766
|
946128-88-7
|
98%
|
|
RO5126766 (CH5126766) is a dual RAF/MEK inhibitor with IC50 of 8.2 nM, 19 nM, 56 nM, and 160 nM for BRAF V600E, BRAF, CRAF, and MEK1, respectively. Phase 1.
|
T6131 |
Pimasertib
|
1236699-92-5
|
98%
|
|
Pimasertib is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
|
T5412 |
RO4987655
|
874101-00-5
|
98%
|
|
RO4987655 is an orally active and highly selective MEK inhibitor (IC50: 5.2 nM for MEK1/MEK2).
|